Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 12/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 12/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 12/20 | 0.41 |
| ▸ | TPSAB1 | Q15661 | 12/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | PPARA | Q07869 | 4/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13899415 | 0.93 | PPARA (0.44) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL10183888 | 0.86 | PPARA (0.54) | PPARGPPARAPPARD | |
| SCHEMBL13899412 | 0.82 | PPARA (0.47) | PPARGPPARAPPARD | |
| SCHEMBL13899414 | 0.81 | PPARA (0.55) | PPARGPPARAPPARD | |
| SCHEMBL10184744 | 0.79 | PPARA (0.51) | PPARGPPARAPPARD | |
| SCHEMBL10184745 | 0.78 | FFAR1 (0.53) | PPARGPPARAPPARD | |
| SCHEMBL10185919 | 0.78 | FFAR1 (0.53) | PPARGPPARAPPARD | |
| SCHEMBL13906064 | 0.77 | PPARA (0.52) | PPARGPPARAPPARD | |
| SCHEMBL13899200 | 0.75 | PPARA (0.55) | PPARGPPARAPPARD | |
| SCHEMBL10185910 | 0.74 | PPARA (0.53) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507757-B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-03-24 | — | — | US | disclosed |
| US-7507757-B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-03-24 | — | — | US | disclosed |